IMD-0560

N/A

Report date: 2025/01/26 18:55:09

NME

Base Information

Drug NameIMD-0560

Drug Alias NameIkappaB Kinase Inhibitor (Institute of Medicinal Molecular Design/Tokyo University)IkappaB kinase inhibitor (Institute of Medicinal Molecular Design/Tokyo University)IKK-Beta Inhibitor (IMMD/Tokyo University)IMD-0560

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInterleukin-6 inhibitorsNuclear factor NF-kappa-B complex inhibitorsInhibitor of nuclear factor kappa-B kinase subunit beta inhibitors

TargetsInhibitor of nuclear factor kappa-B kinase subunit betaInterleukin-6Nuclear factor NF-kappa-B complex

Therapy Area/IndicationsMyocardial InfarctionEndometriosisOsteoarthritis +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Tokyo

China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medicinal Molecular Design Inc

Inactive CompaniesUniversity Of Tokyo

Active IndicationsEndometriosis

Inactive IndicationsMyocardial InfarctionOsteoarthritisArthritis, Rheumatoid

Other Information

ATC CodeN/A